Please assess the completion status of the following clinical trial:

Trial Title: Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* You must be at least 18 years old.~* You must be diagnosed with major depressive disorder~* You must be able to visit the doctor's office once a week to once every 2 weeks for a total of 8 weeks.~Exclusion Criteria:~* You are a woman and are pregnant or breastfeeding.~* You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.~* You have a history of alcohol or drug dependence or abuse within the past 6 months.~* You are allergic to the study drug or you have experienced allergic reactions when taking several medications at once.~* You have a serious medical illness.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).